What Is Neuberger Berman High Yield Str (NHS) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Neuberger Berman High Yield Str presents a highly debated valuation profile at its current price of $6.16. The composite intrinsic value is estimated at $6.58 (+6.8% average upside), masking a wide model spread between the 4 bullish models and 6 bearish models. Model dispersion is worth noting: Markov DDM targets $18.61 (+202.1%), versus Bayesian DCF at $1.64 (-73.4%). This +275.4% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About NHS?
11 of 13 models are currently active for NHS. Of these, 4 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates NHS's intrinsic value at $1.64, implying -73.4% downside from the current price. See which stocks rank higher →
How Does NHS Rank in —?
NHS operates in the — sector. CirclFi's QOC score of 2.0/10 evaluates 32 fundamental signals. A score of 2.0 signals below-average fundamentals.
Neuberger Berman High Yield Str operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is NHS a Value Trap?
The Value Trap algorithm is not active for NHS. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for Neuberger Berman High Yield Str. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Neuberger Berman High Yield Str is rated at 2.0/10. This weak-tier score exhibits fundamental weaknesses that warrant careful scrutiny.
The gap between the most bullish and bearish model spans +275.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every NHS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across NHS's 11 active models, average confidence is 3%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad